Stéphane Postic
Director of Finance/CFO at MEDINCELL S.A.
Stéphane Postic active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MEDINCELL S.A. | Director of Finance/CFO | 2023-08-31 | - |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Chief Executive Officer | 2022-09-05 | - |
Career history of Stéphane Postic
Former positions of Stéphane Postic
| Companies | Position | Start | End |
|---|---|---|---|
GDSA SA
 GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Director/Board Member | - | - |
| GENFIT | Director of Finance/CFO | 2002-03-31 | - |
Statistics
International
| France | 5 |
Operational
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GENFIT | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Private companies | 2 |
|---|---|
GDSA SA
GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Distribution Services |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Stéphane Postic
- Experience
